While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remedisvir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution.    Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading ->
People with COVID-19 are dying at significantly higher rates in communities in the United States with higher air pollution levels, according to a new Harvard University study  – the first such study to systematically examine links between air pollution and higher COVID-19 mortality.  For every 1 microgram/ cubic meter (µg/m3) increase in average annual levels […] Continue reading ->
The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use  in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading ->
A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading ->
The World Health Organization has received more than US $622 million of a US $675 million ask to fund WHO’s first Strategic Preparedness and Response Plan for COVID-19, WHO Director-General Dr Tedros Adhanom Ghebreyesus said on Monday.  “We continue to be encouraged by the signs of global solidarity to confront and overcome this common threat,” […] Continue reading ->
Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met.  In a separate letter signed by 37 […] Continue reading ->
The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday.  Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading ->
Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading ->